multiple sclerosis. Demyelinating disease of central nervous system, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The research sample in this study included all patients with multiple sclerosis, members of the Multiple Sclerosis Association of Zahedan city, whose disease was confirmed by a neurologist and at least 6 months had passed since the diagnosis of their disease.
Exclusion criteria
Exclusion criteria: Occurrence of serious complications of the disease (severe movement disorder, vision), hospitalization or death of the patient during the study. Absence of more than one session in the workshop.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence to treatment and anxiety. Timepoint: Start studying, 1 and 3 months later. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences